Control of Viral Pathogenesis by Regulation of 2-5A Levels
Control of Viral Pathogenesis by Regulation of 2-5A Levels
批准号:
10310409
负责人:
Robert H. Silverman
金额:
$78.89万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-01-01 至 2023-12-31
关键词:
A549ADAR1AcuteAnimal ModelAntiviral ResponseApoptosisApoptoticBindingCell DeathCell SurvivalCellsChildChiropteraCoronavirusDataDouble-Stranded RNAEbolaEbola virusEmbryoEnzymesEpithelialFilovirusGenesGenetic DiseasesGrantHealthHepatitisHumanHuman Cell LineInfectionInflammatoryInterferonsIsoenzymesKnock-outL CellsLigaseLinkLiverLungMarburgvirusMediatingMonitorMusMutateMutationPathogenesisPathogenicityPathologyPathway interactionsPatientsProductionProtein IsoformsProteinsRNARecoveryRegulationResistanceRibonucleasesRoleRotavirusSignal TransductionSystemT cell responseTestingTherapeuticTissuesViralViral PathogenesisVirulence FactorsVirusVirus DiseasesVirus Replicationacute infectionadenosine deaminaseanimal coronavirusantagonistcell typecytotoxicin vivoinhibitorinnovationmouse modelnoveloligoadenylateoverexpressionphosphoric diester hydrolasepreventpseudotoxoplasmosis syndromeresponseviral detection
中文摘要
干扰素(IFN)的诱导和信号传导是由病毒双链DNA引发的早期抗病毒反应。
(ds)RNA。虽然对限制病毒复制和传播至关重要,但IFN应答的过表达可能是
对人体健康有害。例如,Aicardi-Goutiéres综合征(AGS)是一种严重的神经发育障碍,
和炎症性遗传病,其特征在于宿主诱导的IFN产生和信号传导过量
self-dsRNA。因此,重要的是要了解宿主是如何调节由自身诱导的dsRNA途径的。
dsRNA以及病毒(非自身)-dsRNA。寡腺苷酸合成酶-核糖核酸酶L(OAS-RNase L)是一种
有效的抗病毒途径,严重限制了许多病毒的发病机制。在感测dsRNA时,OAS
产生2 ',5'-寡腺苷酸(2-5A),其激活RNase L以切割宿主和病毒单链RNA
从而限制蛋白质产生、病毒复制和传播,并导致凋亡性细胞死亡。期间
上一阶段,我们鉴定并表征了病毒和宿主编码的磷酸二酯酶(PDE),
RNA酶L激活的拮抗剂,最值得注意的是鼠冠状病毒(MHV)的PDE,NS 2,肝特异性
毒力因子我们还鉴定了OAS 3作为人类细胞中的主要抗病毒OAS。此外,我们发现,
RNase L是导致人类细胞系凋亡的主要dsRNA依赖性途径,
外源性双链RNA或通过细胞中的自身双链RNA消除ADAR 1(一种不稳定酶)的表达
dsRNA突变后可导致AGS。然而,在理解如何激活
RNA酶L被控制以防止dsRNA的潜在破坏性作用,同时仍然保持
限制病毒复制和传播。在这个项目的继续中,我们将测试宿主
病毒有多种途径来控制2-5A的水平,其对RNase L的激活以及
RNase L的直接抗病毒以及促凋亡和促炎作用。我们将使用创新的
方法调查OAS-RNase L系统在三个互补的物种特异性系统,每个
具有独特的功能。我们将研究:1)ADAR 1亚型和宿主PDE如何调节2-5A的水平,
人类细胞,并确定哪些OAS亚型参与; 2)如何抗病毒,凋亡和炎症
RNase L的作用协同影响MHV小鼠模型中的病毒清除;以及3)OAS-RNase L如何
OAS-RNase L通路在蝙蝠中表达和激活,并且OAS-RNase L的拮抗作用的潜在机制
丝状病毒VP 35激活。这些研究的结果应该提供更好的理解如何主机
RNA酶控制自身dsRNA和2-5A的水平,以限制未感染细胞中的RNA酶L活性,
病毒感染过程中的激活以及组合的抗病毒,凋亡和促炎作用,
RNA酶L在病毒清除中的作用。这些研究将使我们能够确定增强宿主细胞抵抗力的靶点,
病毒,同时最大限度地减少OAS-RNase L过度激活对宿主的威胁,最后可能有助于
确定病毒性疾病和ADAR 1突变的AGS患者的治疗策略。
英文摘要
Interferon (IFN) induction and signaling is an early antiviral response triggered by viral double-stranded
(ds)RNA. While critical to limiting viral replication and spread, overexpression of the IFN response can be
detrimental to human health. For example, Aicardi-Goutiéres syndrome (AGS) is a severe neurodevelopmental
and inflammatory genetic disease, characterized by excessive IFN production and signaling induced by host
self-dsRNA. Thus it is important to understand how the host regulates dsRNA pathways induced by self-
dsRNA as well as viral (non self)-dsRNA. Oligoadenylate synthetase-ribonuclease L (OAS-RNase L) is a
potent antiviral pathway that severely limits pathogenesis of many viruses. Upon sensing dsRNA, OASs
produce 2',5'-oligoadenylates (2-5A) which activate RNase L to cleave both host and viral single-stranded RNA
thereby limiting protein production, virus replication and spread, and leading to apoptotic cell death. During the
last period we identified and characterized virus- and host-encoded phosphodiesterases (PDEs) as potent
antagonists of RNase L activation, most notably the PDE of murine coronavirus (MHV), NS2, a liver specific
virulence factor. We also identified OAS3 as the principal antiviral OAS in human cells. Moreover, we found
that RNase L is the dominant dsRNA-dependent pathway leading to apoptosis in human cell lines by
exogenous dsRNA or by self-dsRNA in cells ablated for expression of ADAR1, an enzyme that destabilizes
dsRNA and when mutated can cause AGS. However, there is a gap in understanding how the activation of
RNase L is controlled to prevent the potentially destructive effects of dsRNA while still maintaining the ability to
limit viral replication and spread. In the continuation of this project, we will test the hypothesis that the host
and viruses have multiple pathways to control the levels of 2-5A, its activation of RNase L and the
directly antiviral as well as proapoptotic and proinflammatory effects of RNase L. We will use innovative
approaches to investigate the OAS-RNase L system in three complementary species-specific systems, each
with unique features. We will investigate: 1) how ADAR1 isoforms and host PDEs regulate levels of 2-5A in
human cells, and determine which OAS isoforms are involved; 2) how the antiviral, apoptotic and inflammatory
roles of RNase L cooperate to effect viral clearance in an MHV mouse model; and 3) how the OAS-RNase L
pathway is expressed and activated in bats, and the mechanism(s) underlying antagonism of OAS-RNase L
activation by filovirus VP35. Results of these studies should provide a better understanding of how host
enzymes control the levels of self-dsRNA and 2-5A to limit RNase L activity in uninfected cells, while allowing
activation during viral infections as well as the combined antiviral, apoptotic and proinflammatory roles of
RNase L in viral clearance. These studies will allow us to identify targets that enhance host cell resistance to
virus while minimizing the threat of over activation of OAS-RNase L to the host, and finally may contribute to
identifying therapeutic strategies for viral diseases and for AGS patients with mutations in ADAR1.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ANTIVIRAL MECHANISMS OF 2-5A-DEPENDENT RNASE L
-
批准号:9761446
-
项目类别:
-
资助金额:$40.06万
-
财政年份:2017
-
负责人:Robert H. Silverman
-
依托单位:
ANTIVIRAL MECHANISMS OF 2-5A-DEPENDENT RNASE L
-
批准号:10005110
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2017
-
负责人:Robert H. Silverman
-
依托单位:
Control of Viral Pathogenesis by Regulation of 2-5A Levels
-
批准号:8784188
-
项目类别:
-
资助金额:$71.33万
-
财政年份:2013
-
负责人:Robert H. Silverman
-
依托单位:
Control of Viral Pathogenesis by Regulation of 2-5A Levels
-
批准号:10077787
-
项目类别:
-
资助金额:$79.5万
-
财政年份:2013
-
负责人:Robert H. Silverman
-
依托单位:
Control of Viral Pathogenesis by Regulation of 2-5A Levels
-
批准号:8974219
-
项目类别:
-
资助金额:$71.33万
-
财政年份:2013
-
负责人:Robert H. Silverman
-
依托单位:
Control of Viral Pathogenesis by Regulation of 2-5A Levels
-
批准号:8476886
-
项目类别:
-
资助金额:$71.6万
-
财政年份:2013
-
负责人:Robert H. Silverman
-
依托单位:
Control of Viral Pathogenesis by Regulation of 2-5A Levels
-
批准号:9191335
-
项目类别:
-
资助金额:$71.33万
-
财政年份:2013
-
负责人:Robert H. Silverman
-
依托单位:
Control of Viral Pathogenesis by Regulation of 2-5A Levels
-
批准号:10540316
-
项目类别:
-
资助金额:$78.86万
-
财政年份:2013
-
负责人:Robert H. Silverman
-
依托单位:
Control of Viral Pathogenesis by Regulation of 2-5A Levels
-
批准号:8601426
-
项目类别:
-
资助金额:$70.45万
-
财政年份:2013
-
负责人:Robert H. Silverman
-
依托单位:
AMPLIFICATION OF ANTIVIRAL INNATE IMMUNITY BY SUPPRESSOR OF VIRUS RNA (svRNA)
-
批准号:7936346
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:Robert H. Silverman
-
依托单位:
AMPLIFICATION OF ANTIVIRAL INNATE IMMUNITY BY SUPPRESSOR OF VIRUS RNA (svRNA)
-
批准号:7809421
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:Robert H. Silverman
-
依托单位:
Broad Spectrum Antivirals Against Biodefense Select Agents That Activate RNase L
-
批准号:7641948
-
项目类别:
-
资助金额:$34.51万
-
财政年份:2008
-
负责人:Robert H. Silverman
-
依托单位:
THE PREVALANCE OF DIABETES AMONG EMERGENCY DEPARTMENT PATIENTS WITH NO PREVIOUS
-
批准号:7608242
-
项目类别:
-
资助金额:$69.45万
-
财政年份:2007
-
负责人:Robert H. Silverman
-
依托单位:
STRESS HYPERGLYCEMIA IN EMERGENCY DEPARTMENT (ED) PATIENTS: A NORMAL RESPONSE
-
批准号:7377126
-
项目类别:
-
资助金额:$69.72万
-
财政年份:2006
-
负责人:Robert H. Silverman
-
依托单位:
STRESS HYPERGLYCEMIA IN EMERGENCY DEPARTMENT (ED) PATIENTS: A NORMAL RESPONSE
-
批准号:7203207
-
项目类别:
-
资助金额:$16.87万
-
财政年份:2005
-
负责人:Robert H. Silverman
-
依托单位:
Role of RNase L in the Biology of Prostate Cancer
-
批准号:7340175
-
项目类别:
-
资助金额:$29.74万
-
财政年份:2004
-
负责人:Robert H. Silverman
-
依托单位:
Role of RNase L in the Biology of Prostate Cancer
-
批准号:6703242
-
项目类别:
-
资助金额:$31.37万
-
财政年份:2004
-
负责人:Robert H. Silverman
-
依托单位:
Role of RNase L in the Biology of Prostate Cancer
-
批准号:7008850
-
项目类别:
-
资助金额:$30.63万
-
财政年份:2004
-
负责人:Robert H. Silverman
-
依托单位:
Role of RNase L in the Biology of Prostate Cancer
-
批准号:6856518
-
项目类别:
-
资助金额:$31.37万
-
财政年份:2004
-
负责人:Robert H. Silverman
-
依托单位:
Role of RNase L in the Biology of Prostate Cancer
-
批准号:7171854
-
项目类别:
-
资助金额:$29.74万
-
财政年份:2004
-
负责人:Robert H. Silverman
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ADAR1抑制ZBP1介导的干扰素反应的机制研究
-
批准号:32571500
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2025
-
负责人:胡世斌
-
依托单位:
ADAR1抑制Z-DNA累积激活cGAS-STING信号通路并诱导中性粒细胞产生胞外诱捕网引起鼻咽癌放疗抵抗的机制
-
批准号:2025JJ50711
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:王芙艳
-
依托单位:
地榆皂苷I调控TFEB-溶酶体自噬降解ADAR1重启白血病干细胞泛凋亡抗AML的作用和机制研究
-
批准号:82560793
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2025
-
负责人:熊永爱
-
依托单位:
巨噬细胞缺失ADAR1协同IFN-γ通过RNA编辑PRDX1-NLRP3轴抑制肺腺癌的机制研究
-
批准号:82503121
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:林炜炜
-
依托单位:
RNA编辑酶ADAR1调控免疫球蛋白类别转换重组机制研究
-
批准号:32560183
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2025
-
负责人:李宇兴
-
依托单位:
诱导型ADAR1通过DNA-RNA杂合体堆积持续启动滞育样重编程介导舌鳞癌细胞休眠的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:李静远
-
依托单位:
ADAR1抑制ZBP1驱动的神经元程序性坏死改善脑出血继发性损伤机制研究
-
批准号:82471358
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2024
-
负责人:徐阳
-
依托单位:
ADAR1诱导的RNA超编辑促进卵巢癌恶性进展的作用和机制
-
批准号:82472792
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2024
-
负责人:刘招舰
-
依托单位:
ADAR1通过miR-181a-5p-ESM1信号调控母胎界面血管重铸的分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:陈慧
-
依托单位:
ADAR1通过ZBP1介导的PANoptosis促进食管鳞癌抗PD-1/PD-L1免疫治疗耐药的机制研究
-
批准号:82403108
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2024
-
负责人:王思慧
-
依托单位: